Aceclofenac: A Safer Alternative Among NSAIDs?
International Journal of Drug Delivery Technology · 29.04.2026 · 16 (21s)
DOI: 10.25258/ijddt.16.21s.78 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 29.04.2026. Verfasst von Dr. Muthalagappan PL und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely prescribed medications globally for the management of pain, inflammation, and fever. They exert their pharmacological effects primarily through inhibition of cyclooxygenase (COX) enzymes, thereby reducing prostaglandin synthesis. Despite their effectiveness, NSAIDs are associated with significant gastrointestinal, renal, and cardiovascular adverse effects. This review summarizes the pharmacology, classification, dosing considerations, clinical uses, and safety concerns of NSAIDs. Aceclofenac is a widely used non-steroidal anti-inflammatory drug (NSAID) with preferential cyclooxygenase-2 (COX-2) inhibition. It is commonly prescribed in dental practice for the management of pain and inflammation associated with various oral conditions and procedures. This review highlights its pharmacological properties, clinical uses in dentistry, comparative efficacy, and safety profile.
Zitieren
APA
PL, D. M., Swaminathan, D. A., K, D. S. K., & Prem, D. A. (2026). Aceclofenac: A Safer Alternative Among NSAIDs?. International Journal of Drug Delivery Technology, 16(21s). https://doi.org/10.25258/ijddt.16.21s.78
Vancouver
PL DM, Swaminathan DA, K DSK, Prem DA. Aceclofenac: A Safer Alternative Among NSAIDs?. International Journal of Drug Delivery Technology. 2026;16(21s). doi:10.25258/ijddt.16.21s.78
BibTeX
@article{PL2026,
author = {PL, Dr. Muthalagappan and Swaminathan, Dr. Aarthi and K, Dr. Sri Kumar and Prem, Dr. Anjana},
title = {Aceclofenac: A Safer Alternative Among NSAIDs?},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {21s},
doi = {10.25258/ijddt.16.21s.78}
}
EUVIMED